Phase 2 Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2014
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone cancer; Giant cell tumours
- Focus Therapeutic Use
- Acronyms Zometa
- 30 Jan 2013 Last checked against ClinicalTrials.gov record.
- 30 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 04 Apr 2012 New trial record